293 related articles for article (PubMed ID: 15842724)
1. An unequal activism for an unequal epidemic?
Selemogo M
Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
[TBL] [Abstract][Full Text] [Related]
2. Affordable access to essential medication in developing countries: conflicts between ethical and economic imperatives.
Schüklenk U; Ashcroft RE
J Med Philos; 2002 Apr; 27(2):179-95. PubMed ID: 11961696
[TBL] [Abstract][Full Text] [Related]
3. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
4. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
5. Commentary: the reality of treating HIV and AIDS in poor countries.
Sykes R
BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203
[No Abstract] [Full Text] [Related]
6. The XIV International AIDS Conference. Treatment access as a human right.
Achmat Z
Posit Aware; 2002; 13(5):32-5. PubMed ID: 12400489
[No Abstract] [Full Text] [Related]
7. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
8. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
Sawyer E
AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
[TBL] [Abstract][Full Text] [Related]
9. AIDS. Resource needs for HIV/AIDS.
Schwartländer B; Stover J; Walker N; Bollinger L; Gutierrez JP; McGreevey W; Opuni M; Forsythe S; Kumaranayake L; Watts C; Bertozzi S
Science; 2001 Jun; 292(5526):2434-6. PubMed ID: 11423619
[No Abstract] [Full Text] [Related]
10. New public/private sector effort initiated to accelerate access to HIV/AIDS care and treatment in developing countries.
Int J Epidemiol; 2000 Oct; 29(5):956. PubMed ID: 11034986
[No Abstract] [Full Text] [Related]
11. Companies reduce prices for HIV drugs in developing countries.
Gottlieb S
Bull World Health Organ; 2000; 78(6):862. PubMed ID: 10916926
[TBL] [Abstract][Full Text] [Related]
12. Uganda cuts AIDS drug deal.
IAPAC Mon; 2001 Feb; 7(2):40. PubMed ID: 11302022
[No Abstract] [Full Text] [Related]
13. Cooperation forms to accelerate access to AIDS care in developing countries.
AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881360
[No Abstract] [Full Text] [Related]
14. A growing dichotomy: the gap between therapeutic haves and have-nots.
AIDS Alert; 1998 Jan; 13(1):1-4. PubMed ID: 11364861
[TBL] [Abstract][Full Text] [Related]
15. GATT and the gap: how to save lives.
James JS
AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
[TBL] [Abstract][Full Text] [Related]
16. [The war against AIDS continues!].
Trabacchi G
Soins; 2003; (672):13. PubMed ID: 12655816
[No Abstract] [Full Text] [Related]
17. Breakfast with Laurie. Interview by Bob Roehr.
Garrett L
IAPAC Mon; 2000 Nov; 6(11):316-8. PubMed ID: 11299994
[No Abstract] [Full Text] [Related]
18. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
James JS
AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
[TBL] [Abstract][Full Text] [Related]
19. HHS awards $845.7 million in grants for HIV/AIDS care.
Health Care Financ Rev; 2001; 22(4):213. PubMed ID: 12378779
[No Abstract] [Full Text] [Related]
20. Simplifying HIV therapeutics, and the global treatment of AIDS.
Laurence J
AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
